US Broker Ratings

TransMedics Group, Inc. (TMDX): Investor Outlook with an 18.72% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector, specifically within the niche of medical devices. The company is dedicated to revolutionizing organ..

BrightSpring Health Services, I (BTSG) Stock Analysis: Is a 15% Upside Worth the Investment?

Investors with an eye on the healthcare sector may want to consider BrightSpring Health Services, Inc. (BTSG), a prominent player in the Health Information Services industry...

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating Growth Potential and Market Position

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a formidable name in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, has consistently demonstrated its..

Axsome Therapeutics, Inc. (AXSM): A Biotech Gem with 49.31% Potential Upside

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing the attention of investors with a promising 49.31% potential upside, according to analyst target prices. The New York-based biopharmaceutical..

Neurocrine Biosciences, Inc. (NBIX) Investor Outlook: Analysts See Nearly 24% Upside Potential

Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a key player in the healthcare sector specializing in pharmaceuticals for neurological and neuropsychiatric disorders, is drawing significant investor attention. With..

Solventum Corporation (SOLV): Investor Outlook on a 17.9% Potential Upside

Solventum Corporation (NYSE: SOLV) is making waves in the healthcare sector, specifically within the realm of Medical Instruments & Supplies. With a market capitalization of $12.75..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 35.91% Potential Upside

HealthEquity, Inc. (NASDAQ: HQY) stands out in the healthcare sector as a pivotal player in the health information services industry. With a market capitalization of $7.77..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with a 37.54% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) has emerged as a noteworthy player in the biotechnology sector, drawing investor attention with its promising pipeline and significant potential upside...

Waystar Holding Corp. (WAY) Stock Analysis: Unveiling a 39% Upside Potential in Healthcare Innovation

Waystar Holding Corp. (NASDAQ: WAY), a burgeoning leader in healthcare information services, is capturing the attention of investors with its promising growth trajectory and substantial potential..

Tenet Healthcare Corporation (THC) Stock Analysis: A Closer Look at its 10.04% Upside Potential

Tenet Healthcare Corporation (NYSE: THC) stands as a formidable entity within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Uncovering a 21.75% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, with a focus on innovative therapies for cystic fibrosis (CF) and other..

RadNet, Inc. (RDNT) Stock Analysis: Exploring Growth Potential in the Healthcare Diagnostics Sector

For investors seeking opportunities in the healthcare sector, RadNet, Inc. (NASDAQ: RDNT) presents a compelling case with its robust position in the diagnostics and research industry...

Jazz Pharmaceuticals (JAZZ): Investor Outlook Reveals 49% Potential Upside with Strong Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is an intriguing prospect in the biotechnology sector, drawing investor attention with its robust pipeline and significant upside potential. With a..

Option Care Health, Inc. (OPCH) Stock Analysis: Discover a 34.93% Potential Upside in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH) is making waves in the healthcare sector, particularly within the niche market of home and alternate site infusion services. Headquartered..

Haleon plc (HLN) Stock Analysis: Unpacking a 18% Potential Upside for Investors

Haleon plc (HLN) stands out in the healthcare sector with a commanding market capitalization of $44.17 billion, positioning itself as a significant player within the Drug..

Amgen Inc. (AMGN) Stock Report: Navigating Growth with a 6.18% Upside

As a stalwart in the healthcare sector, Amgen Inc. (NASDAQ: AMGN) continues to capture the attention of investors with its robust pipeline and solid market presence...

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a 115% Potential Upside in the Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN) is making waves in the biotechnology sector with its promising advancements in cell therapies, particularly for oncology. As investors look for..

AptarGroup, Inc. (ATR) Investor Outlook: A Solid Healthcare Play with 21% Upside Potential

AptarGroup, Inc. (NYSE: ATR), a key player in the healthcare sector, offers a compelling investment case with a promising 21.26% potential upside. The company, boasting a..

Doximity, Inc. (DOCS) Stock Analysis: Navigating the Healthcare Digital Frontier with a $12.69 Billion Market Cap

Doximity, Inc. (NYSE: DOCS) stands out as a key player in the healthcare sector, offering a digital platform tailored for medical professionals in the United States...

AbbVie Inc. (ABBV) Stock Analysis: Unveiling Growth Potential with a 3.11% Dividend Yield

AbbVie Inc. (ABBV), a prominent player in the healthcare sector, continues to draw investor attention with its robust market cap of $372.04 billion. As a leader..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds